Drawing for CLEARCELL

USPTO serial 85389090

CLEARCELL

Reviewed by CopyMark Law Group

Reg. 4294265Status 800Registered
Filing date
Status date
Registration date
Feb 26, 2013
Examiner
COLEMAN, CIMMERIAN
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with CLEARCELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Instruments for scientific use in treatment of samples before analysis, namely, instruments for detecting and isolating intact circulating tumor cells and other rare cells from small quantities of blood, instruments for staining samples for identification, instruments for retrieving samples for molecular analysis, automated laboratory equipment for cutting samples; detecting apparatus for detecting containments and rare cells for scientific laboratory use; blood cell separation and analyzing apparatus, other than for medical use; [ cell counting units for laboratory use; cases adapted for cells, namely, cell culture plates and bio-chips used for cell cultures and examination, transportation case for cells; specimen collection containers for samples extracted from the body for laboratory use; computer programs for scientific data analysis; computer imaging systems comprising of scanners, digital video recorders and printers; computer programs for image processing; fluid sampling apparatus, namely, medical fluid injectors, fluid handling device used for disposable bioprocessing applications and parts and fittings therefor; ] automated analyses for body fluids, other than for medical use, namely, automatic fluid-composition control machines and instruments, clinical laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids or cells [; apparatus for measuring body fluids, namely, measuring couplings for measuring temperature, pressure, quantity and concentration of fluids in hydraulic or pneumatic systems, rheometers for measuring the viscosity and viscoelasticity of fluids ]ACTIVEAug 31, 2011
010Medical devices for diagnosis of rare cells, medical devices for infusion of fluids and medicine and injection devices for administering drugs, medical cutting devices, [ medical device for detecting cancer, ] medical device for treating cancer; [ medical devices, namely, ultrasound imaging apparatus, scanners and needle guides, and parts and fittings therefor; medical devices for monitoring blood properties; medical devices for obtaining body fluid samples; medical devices, namely, sample preparation device for medical diagnostic uses; detection apparatus for medical use, namely, medical diagnostic apparatus for detecting cancer or rare cells, flow cytometers and flow-based analyzers providing cell and particle detection, for medical use; ] apparatus for blood tests, analysis and monitoring for medical use, namely, blood testing apparatus, namely, blood collecting tubes, blood testing apparatus, namely, blood sampling tubes, blood component separation apparatus for medical purposes, apparatus for blood analysis, filters for blood and blood components, medical devices for monitoring blood properties; blood cell separation and analyzing apparatus for medical use; [ apparatus for medical cell sampling, namely, cell culture chambers for cell sampling; medical apparatus, namely, tubing and syringes assembly set and electromechanical fluidic instrument, and other similar or related devices, which enable blood cells sampling; blood filtration and filtering apparatus; cell counting units for medical use, namely, cell culture chambers, flow cytometers and flow-based analyzers providing cell counting for medical use, single-cell analyses; cell culture apparatus for medical use, namely, cell culture chambers, cell plates and wells; filtering apparatus and automated analyzers for body fluids for medical use, namely, medical filters for blood and blood components, automated medical diagnostic instruments for the analysis of body fluids; implantable devices for medical use in measuring the composition of body fluids; meters for body fluids, namely, medical diagnostic instruments for measuring body fluids; medical infusion pumps; blood extraction devices; ] test and screening devices for medical purposes, namely, cancer diagnostics, cardiovascular diagnostics, fetal cell diagnostics, infectious disease diagnostics, and for screening thereof; medical diagnostic testing apparatus for cancer detection; diagnostic imaging apparatus for medical use; [ apparatus for analyzing images for medical use, namely, medical image processors, cell counting and staining devices; ] specimen collection devices for medical use in extracting samples from the bodyACTIVEAug 31, 2011

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 21, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 21, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 21, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 21, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 21, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 21, 2022NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Mar 21, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 21, 2022RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Mar 21, 202289AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Mar 21, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 1, 2022E89RTEAS SECTION 8 & 9 RECEIVED
Feb 26, 2022REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Mar 6, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 31, 2019NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 31, 2019C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 31, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 15, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 15, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 3, 2019E815TEAS SECTION 8 & 15 RECEIVED
Feb 26, 2018REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 26, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 11, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 11, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 21, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 6, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 5, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 15, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 2012ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 12, 2012GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 12, 2012GNSLLETTER OF SUSPENSION E-MAILED
Jul 12, 2012CNSLSUSPENSION LETTER WRITTEN
Jun 21, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 19, 2012ALIEASSIGNED TO LIE
Jun 6, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 7, 2011GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2011GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2011DOCKASSIGNED TO EXAMINER
Sep 4, 2011TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Sep 4, 2011PARITEAS VOLUNTARY AMENDMENT RECEIVED
Aug 10, 2011MPMKNOTICE OF PSEUDO MARK MAILED
Aug 9, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2011NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance